ScienceDaily Multiple Sclerosis News

Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.
  1. Researchers report that indazole chloride, a synthetic compound that acts on one form of the body's estrogen receptors, is able to remyelinate (add new myelin to) damaged axons and alter the body's immune system -- findings that could help treat multiple sclerosis. Drugs available to treat MS alter the immune system but do not induce repair of damaged axons.
  2. A study sheds new light on the connection between the gut and the brain, untangling the complex interplay that allows the byproducts of microorganisms living in the gut to influence the progression of neurodegenerative diseases.
  3. There is still no cure for multiple sclerosis, with current treatments largely based on managing symptoms, especially accelerating recovery phases following a relapse and reducing the number and severity of relapses. Researchers have now identified a DNA-binding factor called TOX that might play a role in triggering multiple sclerosis. They found that TOX license immune cells to cause autoimmune tissue destruction in the brain.
  4. Multiple sclerosis is a serious neurological condition that has no known cure. Although the causes are far from being known, we do know that the immune system erroneously attacks the protective sheaths around nerve fibers. Scientists have discovered how the formation of myelin sheaths is regulated by protein molecules. This knowledge could be used to help MS patients by stimulating the formation of new myelin sheaths after a relapse.
  5. In March 2017, the US Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 Americans with an estimated 10,000 new cases every year. Neurologists have now looked more deeply into the impact of ocrelizumab in these patients.